Chuck Boyars

Celanese (NYSE: CE), a global chemical and specialty materials company, in its $11 billion acquisition of DuPont’s Mobility & Materials business.

Noble Corporation (NYSE: NE), a provider of offshore oil drilling services, in its all-stock acquisition of Pacific Drilling and its merger with Maersk Drilling. 

Veritas Veterinary Partners, a Percheron Capital portfolio company, in its acquisition of veterinary hospitals from Ethos Veterinary Health pursuant to an FTC-ordered divestiture.

Prince International, an American Securities portfolio company that produces specialty chemicals, minerals, and industrial additives, in its $2.1 billion acquisition of Ferro, and its related divestiture to KPS Capital Partners of the business now known as PEMCO, a producer of porcelain enamel and other products.

Crescent Energy (NYSE: CRGY) in its $815 million acquisition of Uinta Basin assets from Verdun Oil Company pursuant to an FTC-ordered divestiture.

Twilio (NYSE: TWLO), a cloud communications platform, in its $750 million investment in and strategic partnership with Syniverse, a provider of mobile platforms for carriers and enterprises.

Fullscript, a portfolio company of HGGC and Snapdragon Capital Partners that provides a care delivery platform for practitioners of integrative medicine, in its acquisition of Emerson Ecologics. 

Staples in its proposed acquisition of Office Depot.

LaserShip, an American Securities portfolio company, in its acquisition of OnTrac Logistics, a leading provider of last-mile delivery services.  

Carlisle Companies (NYSE: CSL), a supplier of building envelope products and energy-efficient solutions, in its $1.575 billion acquisition of Henry Company, a leading provider of building envelope systems.

GTCR and Corza Health in their acquisitions and merger of Surgical Specialties Corporation and Tacho-Sil, forming Corza Medical, a producer of surgical technology products.

Centerbridge Partners in its acquisitions and combination of daVinci Payments and Wirecard North America, forming North Lane Technologies (now Onbe), a provider of payment technology and solutions.

Delphi Technologies (NYSE: DLPH), a producer of auto parts, in its $3.3 billion sale to BorgWarner.

Ellie Mae, a Thoma Bravo portfolio company offering a cloud-based platform for the mortgage finance industry, in its $11 billion sale to Intercontinental Exchange.

Bristow Group (NYSE: VTOL), a provider of industrial aviation services, including helicopter transport and search and rescue services for the offshore oil & gas industry, in its all-stock merger with Era Group.

Ten-X, a Thomas H. Lee Partners portfolio company that offers an online platform for commercial real estate transactions, in its $190 million sale to CoStar.

Liqui-Box, an Olympus Partners portfolio company that provides flexible packaging solutions, in its $585 million acquisition of DS Smith’s plastics division.

Bristol-Myers Squibb (NYSE: BMY) in its $90 billion acquisition of Celgene, the largest-ever acquisition of a pharmaceutical company, and its related $13.4 billion divesture of Celgene’s OTEZLA® program to Amgen.

A private equity sponsor in its acquisition of a hospice provider.

SoftBank Vision Fund in its investment in ParkJockey (now REEF Technology), a provider of parking technology solutions, and ParkJockey’s acquisition (with Mubadala) of parking facility operators Citizens Parking and Imperial Parking.

PEC Safety (now Veriforce), a Thoma Bravo portfolio company, in its merger with a provider of supply chain risk management and compliance solutions.

Tronox (NYSE: TROX), a vertically integrated producer of titanium dioxide and inorganic chemicals, in its $2.2 billion acquisition of Cristal’s titanium dioxide business, and litigation by the Federal Trade Commission seeking to block the transaction.

Kofax, a Thoma Bravo portfolio company that provides business process software, in its $400 million acquisition of Nuance Document Imaging.

TriMedx, a TowerBrook Capital Partners portfolio company that provides clinical asset management solutions for the healthcare industry, in its $300 million acquisition of Aramark Healthcare Services.

Riskonnect, a Thoma Bravo portfolio company that offers risk management technology solutions, in its acquisition of Marsh ClearSight.

Thoma Bravo in its acquisitions and merger of MeridianLink and CRIF Lending Solutions, which provide software solutions to financial institutions.

Creat Group (owner of Bio Products Laboratory) in its €940 million public takeover of Biotest, a producer of human blood plasma products.

Chesapeake IRB (now Advarra), a Linden Capital Partners portfolio company that provides research compliance solutions, in its merger with Schulman IRB.

Huntsman (NYSE: HUN), a global manufacturer and marketer of differentiated and specialty chemicals, in its proposed merger with Clariant with a combined enterprise value of approximately $20 billion.

WellCare in its $800 million acquisition of Universal American, a provider of Medicare Advantage plans.

Zydus Pharmaceuticals in civil litigation relating to alleged price-fixing of generic drugs.

Italcementi (owner of Essroc Cement) in its $4.1 billion acquisition by HeidelbergCement (owner of Lehigh Hanson).*

Abbott Laboratories (NYSE: ABT) in its $25 billion acquisition of St. Jude Medical, and its related $1.1 billion divestiture of certain vascular closure products and other assets to Terumo.*

Teladoc in litigation against the Texas Medical Board successfully challenging the board’s actions to restrict competition.*

Gilead Sciences in winning dismissal of a purported class action alleging unfair competition and Affordable Care Act violations with respect to its Hepatitis C drugs.*

Goldman Sachs in multiple civil litigations and government investigations relating to residential mortgage-backed securities.*

*Prior to joining Kirkland

Cleary Gottlieb Steen & Hamilton LLP, Washington, D.C., 2014–2016

Sullivan & Cromwell LLP, New York, 2012–2013